Cleared Traditional

K792377 - CARCINOEMBRYONIC ANTIGEN (CEA) CONTROL (FDA 510(k) Clearance)

Sep 1980
Decision
305d
Days
Class 2
Risk

K792377 is an FDA 510(k) clearance for the CARCINOEMBRYONIC ANTIGEN (CEA) CONTROL. This device is classified as a System, Test, Carcinoembryonic Antigen (Class II - Special Controls, product code DHX).

Submitted by Environmental Chemical Specialties (Mchenry, US). The FDA issued a Cleared decision on September 26, 1980, 305 days after receiving the submission on November 26, 1979.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.6010.

Submission Details

510(k) Number K792377 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 26, 1979
Decision Date September 26, 1980
Days to Decision 305 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary

Device Classification

Product Code DHX — System, Test, Carcinoembryonic Antigen
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.6010

Similar Devices — DHX System, Test, Carcinoembryonic Antigen

All 27
Access CEA
K223921 · Beckman Coulter, Inc. · Sep 2023
VITROS Immunodiagnostic Products CEA Reagent Pack
K231517 · Ortho-Clinical Diagnostics · Aug 2023
ADVIA Centaur CEA Assay
K200215 · Siemens Healthcare Disgnostics, Inc. · Apr 2020
OLYMPUS CEA - CARCINOEMBRYONIC ANTIGEN
K081615 · Olympus America, Inc. · Mar 2009
VIDAS CEA (S) ASSAY
K080194 · bioMerieux, Inc. · Oct 2008
DIMENSION VISTA CARCINOEMBRYONIC ANTIGEN FLEX REAGENT CARTRIDGE (CEA)
K071603 · Dade Behring, Inc. · Jun 2008